Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

January 1, 2017; Volume 58,Issue 1
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Brasse, David

    1. You have access
      Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging
      Julien Detour, Alice Pierre, Fréderic Boisson, Guillaume Kreutter, Thomas Lavaux, Izzie Jacques Namer, Laurence Kessler, David Brasse, Patrice Marchand and Alessio Imperiale
      Journal of Nuclear Medicine January 1, 2017, 58 (1) 36-41; DOI: https://doi.org/10.2967/jnumed.116.180588
  2. Brenner, Winfried

    1. You have access
      German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
      Kambiz Rahbar, Hojjat Ahmadzadehfar, Clemens Kratochwil, Uwe Haberkorn, Michael Schäfers, Markus Essler, Richard P. Baum, Harshad R. Kulkarni, Matthias Schmidt, Alexander Drzezga, Peter Bartenstein, Andreas Pfestroff, Markus Luster, Ulf Lützen, Marlies Marx, Vikas Prasad, Winfried Brenner, Alexander Heinzel, Felix M. Mottaghy, Juri Ruf, Philipp Tobias Meyer, Martin Heuschkel, Maria Eveslage, Martin Bögemann, Wolfgang Peter Fendler and Bernd Joachim Krause
      Journal of Nuclear Medicine January 1, 2017, 58 (1) 85-90; DOI: https://doi.org/10.2967/jnumed.116.183194
  3. Brunner, Philippe

    1. You have access
      Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors
      Maria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, Rebecca Dumont, Nicolas Marincek, Attila Kollar, Philippe Brunner, Jan Beyersmann, Jan Müller-Brand, Helmut R. Maecke, Markus Laimer and Martin A. Walter
      Journal of Nuclear Medicine January 1, 2017, 58 (1) 97-102; DOI: https://doi.org/10.2967/jnumed.116.180687
  4. Buvat, Irène

    1. You have access
      Strategies to Inhibit ABCB1- and ABCG2-Mediated Efflux Transport of Erlotinib at the Blood–Brain Barrier: A PET Study on Nonhuman Primates
      Nicolas Tournier, Sebastien Goutal, Sylvain Auvity, Alexander Traxl, Severin Mairinger, Thomas Wanek, Ourkia-Badia Helal, Irène Buvat, Michael Soussan, Fabien Caillé and Oliver Langer
      Journal of Nuclear Medicine January 1, 2017, 58 (1) 117-122; DOI: https://doi.org/10.2967/jnumed.116.178665
  5. Cai, Weibo

    1. You have access
      Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab
      Christopher G. England, Emily B. Ehlerding, Reinier Hernandez, Brian T. Rekoske, Stephen A. Graves, Haiyan Sun, Glenn Liu, Douglas G. McNeel, Todd E. Barnhart and Weibo Cai
      Journal of Nuclear Medicine January 1, 2017, 58 (1) 162-168; DOI: https://doi.org/10.2967/jnumed.116.177857
  6. Caille, Fabien

    1. You have access
      Strategies to Inhibit ABCB1- and ABCG2-Mediated Efflux Transport of Erlotinib at the Blood–Brain Barrier: A PET Study on Nonhuman Primates
      Nicolas Tournier, Sebastien Goutal, Sylvain Auvity, Alexander Traxl, Severin Mairinger, Thomas Wanek, Ourkia-Badia Helal, Irène Buvat, Michael Soussan, Fabien Caillé and Oliver Langer
      Journal of Nuclear Medicine January 1, 2017, 58 (1) 117-122; DOI: https://doi.org/10.2967/jnumed.116.178665
  7. Caplin, Martyn E.

    1. You have access
      Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors
      Emmanouil Panagiotidis, Alshaima Alshammari, Sofia Michopoulou, Evangelia Skoura, Keval Naik, Emmanouil Maragkoudakis, Mullan Mohmaduvesh, Mohammed Al-Harbi, Maria Belda, Martyn E. Caplin, Christos Toumpanakis and Jamshed Bomanji
      Journal of Nuclear Medicine January 1, 2017, 58 (1) 91-96; DOI: https://doi.org/10.2967/jnumed.116.178095
  8. Carlin, Sean

    1. You have access
      Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist
      Hanwen Zhang, Pooja Desai, Yusuke Koike, Jacob Houghton, Sean Carlin, Nidhi Tandon, Karim Touijer and Wolfgang A. Weber
      Journal of Nuclear Medicine January 1, 2017, 58 (1) 29-35; DOI: https://doi.org/10.2967/jnumed.116.176099
  9. Carroll, Peter R.

    1. You have access
      68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience
      Thomas A. Hope, Charles Truillet, Eric C. Ehman, Ali Afshar-Oromieh, Rahul Aggarwal, Charles J. Ryan, Peter R. Carroll, Eric J. Small and Michael J. Evans
      Journal of Nuclear Medicine January 1, 2017, 58 (1) 81-84; DOI: https://doi.org/10.2967/jnumed.116.181800
  10. Celen, Sofie

    1. You have access
      What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2
      Gil Leurquin-Sterk, Sofie Celen, Koen Van Laere, Michel Koole, Guy Bormans, Xavier Langlois, Anne Van Hecken, Paula te Riele, Jesús Alcázar, Alfons Verbruggen, Jan de Hoon, Jose-Ignacio Andrés and Mark E. Schmidt
      Journal of Nuclear Medicine January 1, 2017, 58 (1) 110-116; DOI: https://doi.org/10.2967/jnumed.116.176628
« Previous (Pages : 1 2 3 4 5 6 7 8 9 ... 31) Next »
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 58 (1)
Journal of Nuclear Medicine
Vol. 58, Issue 1
January 1, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
  • Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist
  • 68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience
  • Subjecting Radiologic Imaging to the Linear No-Threshold Hypothesis: A Non Sequitur of Non-Trivial Proportion
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire